The metabolic syndrome is a growing epidemic; it increases the risk for diabetes, 27 cardiovascular disease, fatty liver and several cancers. Several reports have indicated a link 28 between hormonal imbalances and insulin resistance or obesity. Transgenic (TG) female 29 mice overexpressing the human chorionic gonadotropin β-subunit (hCGβ+ mice) exhibit 30 constitutively elevated levels of hCG, increased production of testosterone, progesterone 31 and prolactin, and obesity. The objective of this study was to investigate the influence of 32 hCG hypersecretion on possible alterations in the glucose and lipid metabolism of adult TG 33 females. We evaluated fasting serum insulin, glucose and triglyceride levels in adult 34 hCGβ+ females and conducted intraperitoneal glucose and insulin tolerance tests at 35 different ages. TG female mice showed hyperinsulinemia, hypertriglyceridemia and 36 dyslipidemia, as well as glucose intolerance and insulin resistance at 6 months of age. A 37 one-week treatment with the dopamine agonist cabergoline applied on 5-week-old hCGβ+ 38 mice, which corrected hyperprolactinemia, hyperandrogenism, and hyperprogesteronemia, 39 effectively prevented the metabolic alterations. These data indicate a key role of the 40 hyperprolactinemia-induced gonadal dysfunction in the metabolic disturbances of hCGβ+ 41 female mice. The findings prompt further studies on the involvement of gonadotropins and 42 prolactin on metabolic disorders and might pave the way for the development of new 43 therapeutic strategies. 44 45
Page 2 of 39
mRNA expression that may cause a decreased glucose uptake in peripheral tissues (Nilsson 74 et al., 2009 ). Moreover, prolactin induces pyruvate dehydrogenase kinase 4 (PDK4), whose 75 activation is known to lead to decreased glucose oxidation (White et al., 2007) . In addition, 76 this hormone participates in perinatal brown adipocyte differentiation and function 77 (Viengchareum et al., 2008) , and also affects energy homeostasis through modulation of 78 lipid metabolism (Carre and Binart, 2014). 79
We have previously shown the implications of chronically elevated levels of hCG in 80 the phenotype of transgenic (TG) mice. Particularly, female mice overexpressing the 81 hCGβ-subunit (hCGβ+) exhibit precocious puberty, elevated serum levels of hCG, 82 prolactin, testosterone and progesterone, and present with infertility (Rulli et al., 2002; 83 Ratner et al., 2012) . Besides, hCGβ+ ovaries show hemorrhagic cysts and massive 84 luteinization as a result of the active stimulation with hCG (Rulli et al., 2002; Ratner et al., 85 2012 ). Among the extragonadal phenotypes, these females develop obesity, pituitary 86 hr fasting, and cardiac blood was obtained immediately thereafter. Serum samples were 147 separated by centrifugation and stored at -20 C for biochemical analyses. Pancreata were 148 perfused with RNAlater (Ambion) immediately after dissection, and then snap frozen and 149 stored at -70 C for RNA isolation. The bioactive levels of circulating hCG were determined by the mouse testicular 164 interstitial cell in vitro bioassay as previously described (Ding and Huhtaniemi, 1989; Rulli 165 et al, 2002) . Briefly, decapsulated testes from adult WT males were dispersed with 166 collagenase type I (0.15 mg/ml) in M199 medium (Sigma-Adrich) for 5 min at 34 C. The 167 supernatant was filtered through nylon mesh (mesh size 100 µm) and the cell suspension was washed twice with M199 medium supplemented with 0.1% (w/v) bovine serum 169 albumin (BSA; Sigma-Aldrich) and 20mM HEPES (Sigma-Aldrich). Testicular interstitial 170 cells obtained using this technique are predominantly Leydig cells, as described previously 171 (Ding and Huhtaniemi, 1989) . Cells (50 000 cells/tube) were incubated with increasing 172 concentrations of recombinant hCG as standard (AFP8456A, 20000 IU/mg; NHPP, 173 NIDDK), or with the serum samples, in a 95%O 2 /5%CO 2 atmosphere at 34 C for 4 h. After 174 incubation, supernatants were recovered by centrifugation and frozen at -20 C. The 175 testosterone concentration in the supernatants was measured by radioimmunoassay, 176 according to a method described previously (Ratner et al., 2012) . The intra-and inter-assay 177 coefficients of variation were less than 12%. 178 179
In vivo peripheral tissue response to insulin 180
Six-month-old WT and hCGβ+ female mice were fasted for 4 h. Then, animals were 181 anesthetized with 2% avertin (12 ml/kg i.p.). The abdominal cavity was opened and 2 IU/kg 182 of insulin was injected into the portal vein. At time points 0 and 5 min post-injection, 183 portions of skeletal muscle were excised and flash frozen in liquid N 2 and stored at − Pancreata from 6-month-old WT, hCGβ+ and hCGβ+cab female mice were fixed in 209 4% paraformaldehyde, dehydrated and embedded in paraffin wax. Endogenous peroxidase 210 reactivity was quenched by a 20-min pretreatment with 10% methanol, 0.3% H 2 O 2 in 211 0.01 M PBS (pH 7.4). For antigenic retrieval, sections were pretreated with citrate buffer 212 (0.01M, pH 6), and permeabilized by a 5-min incubation with 0.5% saponin in PBS and 5-213 min incubation with proteinase K (10 ng/ml). Non-specific proteins were blocked by 214 subsequent incubation with protein blocking buffer (5% goat normal serum in PBS for steps, sections were incubated with antibodies rabbit anti-Pdx1 (Millipore, CA, # 06-1379: 217 1/1000) and mouse anti-Nkx 6.1 (DSHB, # F55A10-S: 1/250) diluted in incubation buffer 218 (2% goat normal serum in PBS for Pdx1; 2% horse normal serum in PBS for Nkx 6.1) 219 overnight in a humidified chamber at 4 C. On the second day, pancreata sections were 220 washed and incubated with biotinylated secondary antiserum (goat anti-rabbit IgG; horse 221 anti-mouse IgG, 1:500, Vector Lab., CA, USA) for 2 h at room temperature. Finally, 222 immunoreaction was visualized with 0.01% H 2 O 2 and 0.05% 3,3-diaminobenzidine 223 solution (in 0.05 M Tris-HCl, pH 7.6) and an avidin-biotin-peroxidase system (Vector 224 Lab). Negative controls were performed in the absence of the primary antibodies. 225
226

RNA isolation and analysis of gene expression 227
Total RNA was isolated from pancreata as previously described ( , where E is the efficiency of the primer set and ∆Ct= Ct (reference cDNA) -Ct 244 (experimental cDNA). The amplification efficiency of each primer set was calculated from 245 the slope of a standard amplification curve of log (nanograms of cDNA) per reaction vs. Ct 246 value (E = 10 -(1/slope) ). Efficiencies of 2±0.1 were considered optimal. Results were 247 expressed relative to a reference sample (WT choosen ad random). 248 249
Statistical Analysis 250
Data are expressed as the mean ± SEM. Statistical analysis for comparing two sets 251 of data was performed with Student's t test for two independent groups. In those 252 experiments where the effects of two factors (genotype and treatment) were studied, the 253 two-way ANOVA was performed. The two-way ANOVA with repeated measures was used 254 for the glucose and insulin tolerance tests. Bonferroni's post-hoc test was used to establish 255 the level of significance between group pairs. The trapezoidal rule was used to determine 256 the area under the curve (AUC). Data were transformed when required. A p value less than 257 0.05 was considered significant. 258 259
Results 260
Hormonal and metabolic status of hCGβ+ female mice 261
We have previously demonstrated that at 6 months of age, hCGβ+ female mice 262 showed pronounced disturbances in their gonadal and non gonadal phenotype (Rulli et al., significant increase in body weight, abdominal white fat depot and serum levels of 265 bioactive hCG as compared with WT (p<0.01) (Rulli et al., 2002; Ratner et al., 2012) . This 266 change, however, was not accompanied by an increase in the daily food intake. At this age, 267 serum levels of insulin and triglycerides were elevated in TG females (p<0.001). On the 268 other hand, serum fasting glucose, cholesterol and HDL-C levels did not show differences 269 between WT and hCGβ+ females (Table 1 ). In addition, the atherogenic (or Castelli) index, 270
represented by the ratio of cholesterol/HDL-C, did not show significant differences 271 between the groups, whereas the triglycerides/HDL-C ratio showed a statistically 272 significant increase in hCGβ+ females as compared with WT females (p < 0.001). From 273 fasting insulin and glucose data, we calculated the surrogate indexes of insulin sensitivity 274 and resistance HOMA-IR and QUICKI. The values of HOMA-IR were significantly higher 275 in the hCGβ+ group compared with WT (p<0.05; Table 1) 
Age-dependent changes in the glucose homeostasis of hCGβ+ females 281
In order to study a possible correlation with age, IGTT and ITT were performed in 282 2, 3 and 6-month-old WT and hCGβ+ females. No differences were found in IGTT at two 283 months of age ( Fig. 1 A) . At 3 and 6 months of age, TG females showed glucose 284 intolerance, represented by a delay in glucose clearance and an increase in glucose levels 285 through the different time-points analyzed after glucose administration ( Fig. 1 B,C) . 286
represented as the AUC, were significantly increased in hCGβ+ females as compared with 288 WT (p<0.01). 289
The ITT performed in 2 and 3 month-old TG females showed a quick decline in 290 glucose levels at 30 min after insulin administration, and remained low thereafter, as it was 291 observed in WT females at the same ages ( Fig. 2 A,B) . However, 6-month-old hCGβ+ 292 females showed elevated glucose levels after insulin administration, which remained high 293 through the different time-points analyzed (Fig. 2 C) . Accordingly, the AUC resulted 294 elevated in hCGβ+ females (p<0.01). 295
The insulin secretion capacity in response to glucose administration was performed 296 in 3-and 6-month-old WT and hCGβ+ females (Fig. 3A ). The glucose response was first 297 measured at 30 min, meaning that only the second phase of insulin secretion was detected 298 in this study (Caumo and Luzi, 2004). TG mice from both ages exhibited elevated basal 299 insulin levels as compared with WT females. The insulin secretion of WT females from 300 both ages showed a correct response to glucose stimulation with at least a 2.5-fold increase 301 at 30 min post-glucose administration (p<0.05). Conversely, 3-and 6-month-old hCGβ+ 302 mice exhibited an impaired glucose-stimulated response, being only a 0.8 and 1-fold 303 increase, respectively ( Fig. 3A) . 304
Since TG female mice showed profound alterations in glucose metabolism at 6 305 months of age, we further analyzed the peripheral insulin sensitivity at this age. To this aim, 306
we determined the status of insulin-induced AKT phosphorylation in skeletal muscle 307 obtained from fasted WT and hCGβ+ mice ( Fig 3B) . As expected, WT females showed a 3-308 fold increase in insulin-stimulated AKT phosphorylation (p<0.05), whereas TG females 309 exhibited a severely impaired AKT activation, with levels comparable to basal of both (p<0.05). 312
Taken together these results showed that 6-month-old hCGβ+ females exhibited 313 peripheral insulin resistance and impaired glucose tolerance, being the most important 314 disruptions in glucose homeostasis. 315 316
Effect of cabergoline on the glucose and lipid homeostasis of hCGβ+ females. 317
Treatment with the dopaminergic agonist cabergoline was carried out to analyze the 318 influence of hyperprolactinemia on serum insulin, glucose and triglycerides. It was 319 confirmed that a short-term treatment with cabergoline administered at 5 weeks of age to 320 hCGβ+ females (hCGβ+cab) was effective in the normalization of prolactin levels 321 (p<0.001; Fig 4B) Cabergoline treatment administered to 5-week-old WT females (WTcab), did not produce 325 any effect on the parameters studied ( Fig. 4 A-D). 326 327
Effect of cabergoline on IGTT and ITT of hCGβ+ females 328
IGTT and ITT were performed to further analyze the influence of prolactin on the 329 glucose homeostasis of the TG females (Fig. 5 ). The IGTT showed a similar clearance in 330 WT and WTcab females, with significantly increased glucose levels of hCGβ+ females at 331 30, 60 (p<0.001) and 90 (p<0.01) min after glucose administration ( Fig. 5 A) . hCGβ+ 332 females treated with cabergoline showed a significant reduction of the glucose levels at 30 exhibited similar results ( Fig. 5 B) . 335
The ITT demonstrated that cabergoline treatment fully prevented the appearance of 336 insulin resistance in TG females (Fig. 5 C) . This was confirmed by analyzing the AUC: 337 complete normalization occurred in cabergoline treated TG females with respect to control 338 hCGβ+ females (p<0.05; Fig. 5 D) . 339 340 Effect of cabergoline on pancreatic Ins1, Ins2, Gcg, Pdx1 and Nkx 6.1 in hCGβ+ 341
females. 342
Due to the effectiveness of the cabergoline treatment in normalizing the glucose 343 homeostasis of TG females, we assessed gene expression for preproinsulin (Ins1 and Ins2) 344 and glucagon (Gcg) in pancreatic tissue of 6-month-old hCGβ+ and hCGβ+cab females. In 345 agreement with the increased serum levels of insulin, hCGβ+ females exhibited 346 significantly increased gene expression of both Ins1 and Ins2, as compared with WT 347 females (p<0.05, Fig 6A) . The cabergoline treatment restored the expression levels of the 348 genes for insulin to the level obtained in WT mice ( Fig. 6 A) . In contrast, the expression of 349
Gcg did not show significant differences among the groups studied (Fig. 6A ). The 350 cabergoline treatment applied to WT females did not affect the expression levels of the 351 genes analyzed. 352
In addition, we performed immunohistochemistry for two well known markers of β-353 cell maturity and identity, PDX1 and NKX 6.1. The presence of both markers was detected 354 in the pancreatic islets of WT, hCGβ+ and hCGβ+cab, and the expected nuclear 355 localization was observed ( Fig 6B) . Data are presented as mean±SEM, the number of animals used in each determination is indicated in brackets. Student´s t-test: * p<0,05; ** p<0,01; *** p<0,001.
WT hCGβ+
Body weight (g) 24,7 ± 0,7 (7) 34,9 ± 2,0*** (7)
Daily food intake (g/mouse) 4,42±0,20 (7) 4,43±0,27 (7)
Abdominal white fat (g) 1,79±0,35 (7) 3,72±0,42** (7)
Bio hCG (IU/L) 1,79 ± 0,15 (4) 23,46 ± 8,66*** (4)
Glucose (mg/dl) 152±7 (5) 145±10 (7) Insulin (ng/ml) 0,21±0,07 (5) 1,07±0,21*** (7)
HOMA-IR 1,78±0,65 (5) 8,78±2,12** (7)
QUICKI 0,37±0.02 (5) 0,29±0.01** (7)
Triglycerides (mg/dl) 147±14 (5) 634±61 *** (5)
Cholesterol (mg/dl) 130±14 (4) 177±18 (5)
HDL-C (mg/dl) 82±4 (4) 95±5 (5)
Cholesterol/HDL ratio 1,59±0,18 (4) 1,86±0,14 (5)
Triglycerides/HDL ratio 1,78±0,11 (4) 6,79±0,22*** (5) Figure 1 . Intraperitoneal Glucose Tolerance Test (IGTT) in hCGβ+ female mice at 2, 3 and 6 month of age. IGTT (2 g/kg) in fasted WT and hCGβ+ females was performed at 2 (A), 3 (B) and 6 (C) months of age. Two-way ANOVA with repeated-measures, followed by Bonferroni's post hoc test was conducted; * p<0,05; ** p<0,01; *** p<0,001. The area under the curve (AUC) was analyzed for each group at different ages;
Student´s t-test was conducted; ** p<0,01. Data are presented as mean±SEM (n=4-7). 165x86mm (300 x 300 DPI) Figure 2 . Intraperitoneal Insulin Tolerance Test (ITT) in hCGβ+ female mice at 2, 3 and 6 month of age. ITT (0,75 IU/kg) in fasted WT and hCGβ+ females was performed at 2 (A), 3 (B) and 6 (C) months of age. Twoway ANOVA with repeated-measures, followed by Bonferroni's post hoc test was conducted; * p<0,05; *** p<0,001. The area under the curve (AUC) was analyzed for each group at different ages; Student´s t-test was conducted; ** p<0,01. Data are presented as mean±SEM (n=4-7). 165x89mm (300 x 300 DPI) Figure 3 . (A) Glucose-stimulated insulin release in 3-and 6-month-old hCGβ+ female mice. Glucose (2 g/kg) was administered i.p. to fasted WT and hCGβ+ female mice, and serum insulin levels were measured at 0 and 30 min post-glucose. Two-way ANOVA with repeated-measures, followed by Bonferroni's post hoc test was conducted. Data are presented as mean±SEM (n=4). *: P<0.05; **: p<0.01. (B) Peripheral tissue response to insulin. A representative western blot was shown for AKT activation in skeletal muscle. Samples were obtained from fasted 6-month-old WT and hCGβ+ female mice at 0 or 5 min after insulin administration. Two-way ANOVA followed by Bonferroni's post hoc test or Student's t-test was conducted according to each case. Different letters indicate a value of at least p<0.05. Data are presented as mean±SEM (n=4). 36x15mm (300 x 300 DPI) Figure 4 . Effect cabergoline on body weight and serum levels of prolactin, insulin, and triglycerides in hCGβ+ females. Body weight (A) and serum prolactin (B), insulin (C) and trygicerides (D) levels in 6-month-old cabergoline-treated transgenic females (hCGβ+cab) after 18 hr fasting. WT, cabergoline-tretated WT (WTcab) and hCGβ+ females were used as controls. ANOVA, followed by Bonferroni's post hoc test was conducted. Different letters indicate a value of at least p<0,05. Data are presented as mean±SEM (n=4-12).
132x119mm (300 x 300 DPI) Figure 5 . Effect of cabergoline treatment on the glucose homeostasis in WT and hCGβ+ females. IGTT (2 g/kg) (A), and ITT (0,75 IU/kg) (C) in fasted 6-month-old cabergoline-treated transgenic (hCGβ+cab) females was performed; fasted 6-month-old WT, cabergoline-treated WT (WTcab) and hCGβ+ females were used as control groups. Two-way ANOVA with repeated-measures, followed by Bonferroni's post hoc test was conducted. A) WT vs hCGβ+ **: p<0,01; ***: p<0,001; hCGβ+ vs hCGβ+cab ##: p<0,01; C) hCGβ+ vs WT, WTcab, hCGβ+cab; **: p<0,01, ***: p<0,001. The area under the curve (AUC) was analyzed for the different groups (B, D). ANOVA followed by Bonferroni's post hoc test was conducted. Different letters indicate a value of at least p<0,05. Data are presented as mean±SEM (n=4-12). 132x87mm (300 x 300 DPI) Figure 6 . (A) Effect of cabergoline on the pancreatic gene expression of Ins1, Ins2, Gcg and Ccnd2. The mRNA expression analysis of Ins1, Ins2 and Gcg from fasted 6-month-old WT, hCGβ+ and cabergolinetreated WT (WTcab) and hCGβ+ (hCGβ+cab) pancreata was carried out by qRT-PCR. ANOVA, followed by Bonferroni's post hoc test, was conducted. Different letters indicate a value of at least p< 0.05. Data are presented as mean mean±SEM (n=4). (B) immunolocalization of PDX1 and NKX 6.1 in pancreas. Representative sections from 6-month-old WT, hCGβ+ and hCGβ+cab female mice were immunostained with PDX1 and NKX 6.1 specific antibodies. Scale bar 100 µm. 130x112mm (300 x 300 DPI)
